FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

732937005: Capsule (unit of presentation)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3498398019 Capsule (unit of presentation) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3498399010 Capsule en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Capsule Is a Unit of presentation true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely levothyroxine sodium anhydrous 100 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely levothyroxine sodium anhydrous 100 microgram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely valproic acid 125 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely potassium chloride 750 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely potassium chloride 750 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely duloxetine (as duloxetine hydrochloride) 40 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely duloxetine (as duloxetine hydrochloride) 40 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely phenytoin sodium 300 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely phenytoin sodium 300 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely halibut liver oil 4000 unit/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely halibut liver oil 4000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely fenofibric acid 45 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely duloxetine (as duloxetine hydrochloride) 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely duloxetine (as duloxetine hydrochloride) 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely lansoprazole 30 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely phenytoin sodium 200 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely phenytoin sodium 200 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely valproic acid 250 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely nystatin 1 million unit/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 1 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely potassium chloride 600 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely potassium chloride 600 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely polythiazide 500 microgram and prazosin (as prazosin hydrochloride) 2 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely ergocalciferol 50000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit False Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely ergocalciferol 50000 unit/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 3
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely topiramate 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely topiramate 50 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit False Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 15 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely cyclobenzaprine (as cyclobenzaprine hydrochloride) 30 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit False Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 28 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 28 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely droxidopa 100 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely droxidopa 100 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely linaclotide 145 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 145 microgram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely droxidopa 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 7 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 7 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely fenofibric acid 135 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely fenofibric acid 135 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely linaclotide 290 microgram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely lansoprazole 15 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 90 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely fluoxetine (as fluoxetine hydrochloride) 90 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 14 milligram/1 each prolonged-release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely memantine hydrochloride 14 milligram/1 each prolonged-release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely topiramate 25 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely droxidopa 200 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely topiramate 15 milligram/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely topiramate 15 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely miconazole nitrate 1.2 gram/1 each conventional release vaginal capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely miconazole nitrate 1.2 gram/1 each conventional release vaginal capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely omeprazole 40 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely omeprazole 40 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit False Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation False Capsule Inferred relationship Existential restriction modifier
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier
Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 1
Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 3
Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator unit True Capsule Inferred relationship Existential restriction modifier 2
Product containing precisely amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit/1 each conventional release oral capsule (clinical drug) Has unit of presentation True Capsule Inferred relationship Existential restriction modifier

Start Previous Page 18 of 40 Next End


This concept is not in any reference sets

Back to Start